Pembrolizumab-associated immune-related hepatitis: a retrospective case report analysis - Top-Institutions - MDSpire

Pembrolizumab-associated immune-related hepatitis: a retrospective case report analysis

  • By

  • Ke-qian Chen

  • Yang Chen

  • Jing-Fu Peng

  • Yi Huang

  • Xiang Liu

  • June 17, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Chinese University of Hong Kong
    Chinese University of Hong Kong

    Hong Kong, HK

    Key Differentiators

    • Hepatology

  • #2

    The University of Texas Southwestern Medical Center
    The University of Texas Southwestern Medical Center

    Dallas, TX

    Key Differentiators

    • Hepatology

  • #3

    University of Michigan
    University of Michigan

    Ann Arbor, MI

    Key Differentiators

    • Hepatology

  • #4

    Michigan Medicine
    Michigan Medicine

    Ann Arbor, MI

    Key Differentiators

    • Hepatology

  • #5

    City of Hope National Medical Center
    City of Hope National Medical Center

    Duarte, CA

    Key Differentiators

    • Hepatology

Original Source(s)

Pembrolizumab-associated immune-related hepatitis: a retrospective case report analysis

  • by Ke-qian Chen, Yang Chen, Jing-Fu Peng, Yi Huang, Xiang Liu

  • June 17, 2026

Related Content

Artificial intelligence for biomarker prediction in gastric cancer: from histopathology to multimodal integration

CT-based radiomics improves survival prediction in colorectal liver metastases: beyond clinical scores

Editorial: Understanding oral health challenges in pediatric and adult cancer care